SUDEEPPHRM Share Price | Sudeep Pharma Ltd Stock Analysis & Recommendation

Q: Why is Sudeep Pharma Ltd falling/rising?

As of 04-Mar, Sudeep Pharma Ltd's stock price is falling, currently at Rs 581.00, which reflects a decrease of Rs 17.7 or 2.96%. The stock has been underperforming, with a notable decline of 10.24% over the past week, compared to a 3.84% drop in the Sensex. Additionally, the stock has experienced a consecutive fall over the last three days, resulting in a total decline of 11.6% during this period.Today's performance indicates that Sudeep Pharma is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. The stock also touched an intraday low of Rs 580, marking a decrease of 3.12%. Despite a rise in investor participation, with delivery volume increasing by 50.1% against the 5-day average, the overall market sentiment appears negative, contributing to the stock's decline.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

65.01 k (-29.29%) Volume

Shareholding (Dec 2025)

FII

1.67%

Held by 13 FIIs

DII

10.86%

Held by 11 DIIs

Promoter

76.15%

When is the next results date for Sudeep Pharma?

17-Dec-2025

The next results date for Sudeep Pharma is 19 December 2025.

View full answer

Why is Sudeep Pharma Ltd falling/rising?

05-Mar-2026

As of 04-Mar, Sudeep Pharma Ltd's stock price is Rs 581.00, down 2.96%, with a 10.24% decline over the past week. The stock is trading below all key moving averages, indicating a bearish trend despite increased investor participation.

View full answer

Which are the latest news on Sudeep Pharma?

05-Mar-2026

When is the next results date for Sudeep Pharma?

Compare Sudeep Pharma with Similar Stocks

Akums Drugs Blue Jet Health Strides Pharma

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 6,552 Cr (Small Cap)

P/E

47.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.10

Return on Equity

19.15%

Price to Book

9.06

Revenue and Profits:

Net Sales:

172 Cr

(Quarterly Results - Dec 2025)

Net Profit:

47 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-11.95%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Sudeep Pharma for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

When is the next results date for Sudeep Pharma?

The next results date for Sudeep Pharma is scheduled for 19 December 2025....

Read full news article

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

12-Feb-2026 | Source : BSE

Submission of Earnings Call Transcript for the earnings call held on 9th February 2026 to discuss the operational and financial performance of the Company for the third quarter and nine months ended on 31st December 2025.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

09-Feb-2026 | Source : BSE

Submission of Audio Link for the call held on 9th February 2026

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

09-Feb-2026 | Source : BSE

Submission of Audio Link for the Investors Call held on 9th February 2026

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

37.35

Debt to EBITDA (avg)

0.74

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.60

Tax Ratio

24.13%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

19.27%

ROCE (avg)

23.00%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

9.06

EV to EBIT

37.01

EV to EBITDA

34.94

EV to Capital Employed

8.30

EV to Sales

13.22

PEG Ratio

Dividend Yield

ROCE (Latest)

22.44%

ROE (Latest)

19.15%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

KST

Dow Theory

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 13 Schemes (5.67%)

FIIs

Held by 13 FIIs (1.67%)

Promoter with highest holding

Riva Resources Private Limited (40.35%)

Highest Public shareholder

Nuvama Crossover Opportunities Fund - Series Iii (3.42%)

Individual Investors Holdings

3.27%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 2.73% vs 9.62% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -9.65% vs 18.02% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "90.28",
          "val2": "87.88",
          "chgp": "2.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.61",
          "val2": "30.87",
          "chgp": "-4.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.63",
          "val2": "2.03",
          "chgp": "-68.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "26.87",
          "val2": "29.74",
          "chgp": "-9.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.80%",
          "val2": "35.13%",
          "chgp": "-2.33%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "168.06",
          "val2": "168.40",
          "chgp": "-0.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "61.27",
          "val2": "60.03",
          "chgp": "2.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.47",
          "val2": "1.99",
          "chgp": "74.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "54.95",
          "val2": "41.98",
          "chgp": "30.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.46%",
          "val2": "35.65%",
          "chgp": "0.81%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "258.34",
          "val2": "251.88",
          "chgp": "2.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "90.88",
          "val2": "86.49",
          "chgp": "5.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.10",
          "val2": "3.24",
          "chgp": "26.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "81.82",
          "val2": "62.61",
          "chgp": "30.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "35.18%",
          "val2": "34.34%",
          "chgp": "0.84%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "356.73",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "131.96",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "4.81",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "95.75",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.99%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

90.28

87.88

2.73%

Operating Profit (PBDIT) excl Other Income

29.61

30.87

-4.08%

Interest

0.63

2.03

-68.97%

Exceptional Items

0.00

Standalone Net Profit

26.87

29.74

-9.65%

Operating Profit Margin (Excl OI)

32.80%

35.13%

-2.33%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 2.73% vs 9.62% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -9.65% vs 18.02% in Sep 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

168.06

168.40

-0.20%

Operating Profit (PBDIT) excl Other Income

61.27

60.03

2.07%

Interest

3.47

1.99

74.37%

Exceptional Items

0.00

Standalone Net Profit

54.95

41.98

30.90%

Operating Profit Margin (Excl OI)

36.46%

35.65%

0.81%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

258.34

251.88

2.56%

Operating Profit (PBDIT) excl Other Income

90.88

86.49

5.08%

Interest

4.10

3.24

26.54%

Exceptional Items

0.00

Standalone Net Profit

81.82

62.61

30.68%

Operating Profit Margin (Excl OI)

35.18%

34.34%

0.84%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Change(%)

Net Sales

356.73

Operating Profit (PBDIT) excl Other Income

131.96

Interest

4.81

Exceptional Items

0.00

Standalone Net Profit

95.75

Operating Profit Margin (Excl OI)

36.99%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Sudeep Pharma Ltd

Sudeep Pharma Ltd

Small Cap

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available